Navigation Links
Hormone-replacement therapy could hurt heart

Hormone-replacement therapy could increase the risks of coronary heart disease in healthy women, and it has no effect on patients suffering from atherosclerosis, according to two studies released yesterday.
The studies, published in the Aug. 7 issue of the New England Journal of Medicine, expand on the discouraging results of previous studies on the use of estrogen-and-progestin-based hormone replacement therapy //to help combat heart disease.

This study and others like it "clearly tell us that estrogen and progestin should not be used to treat atherosclerosis in women who already have cardiovascular disease," noted Dr. Howard Hodis, who led the study. Hormone therapy in healthy women is most often used to ease the uncomfortable side effects of menopause, such as hot flashes.

The results of the other study released yesterday offered equally little encouragement for healthy women. The study of 16,000 women, expected to take eight years, was called to a halt after five years because the risks were found to outweigh the benefits, according to officials at Harvard Medical School.

The researchers found there was an increased risk of heart disease after the first year of estrogen and progestin therapy in otherwise healthy postmenopausal women. "This treatment should not be prescribed for the prevention of cardiovascular disease," the authors concluded.
'"/>




Page: 1

Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Antioxidants protect health tissue in people undergoing radiation therapy.
3. Distraction therapy found very effective in postoperative patients
4. Acupuncture superseeds massage therapy for short term relief of pain
5. Ovarian cancer in relationship with Hormone therapy
6. New therapy better at increasing bone density
7. Gene therapy - Aim to improve blood flow
8. Gene therapy restores sight
9. Heat therapy relieves back pain
10. Radiotherapy helps in colon cancer
11. New therapy for pimples
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hormone replacement therapy could hurt heart

(Date:1/22/2015)... AZ (PRWEB) January 22, 2015 Padre Murphy's ... long supporter of Pro Player Health Alliance (PPHA). ... Padre Murphy's in getting everyone, including NFL greats, treated for ... of the leading groups supporting the cause in the valley. ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together by ... up to 30lbs in less than 12 weeks without traditional ... prompting an investigative review. , “Our Incredible Bulk review ... that allows the body to pack on a massive amount ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) ... to “Live Fearless.” , The “Faces of Fearless” ... about how they or someone they know has faced a ... the moment. By telling these types of stories through livefearlessmn.com, ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 A ... issue of experience and person-centeredness in the long-term care ... towards action across the continuum. The paper, “The Power ... Continuum,” engages perspectives and practices of the patient, resident ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3
... two ,good, copies slows age-linked mental decline by half, study ... variant that is good for the heart also appears to ... function and cutting the odds for Alzheimer,s disease, a study ... form of the gene, it reduces the risk of Alzheimer,s ...
... , , DALLAS and ... Fey , chairman and CEO of U.S. Preventive Medicine, today announced ... chairman of the board. Dr. Loeppke will work with the organization,s ...  He will also continue in his role as co-chairman of the ...
... curbs inflammatory processes linked to heart disease, experts say , ... , Fat that settles around the thighs and buttocks may ... In fact, a new review of the data on the ... "It is the protective role of lower body, that is, ...
... , , SHENZHEN, China , Jan. ... www.htdsmedical.com ) announced that its directors have resolved that up to ... of its MindUp division to Hiru will be distributed to HTDS ... Yuan , HTDS President, said, "In our efforts to maximize shareholder ...
... The American College of Physicians (ACP) has issued ... patients, physicians, and caregivers. The Journal ... Caregivers, Patients and Physicians: Ethical Guidance to Optimize ... resources to help physicians manage relationships with patients ...
... autologous stem cell transplantation can extend "event-free survival" for ... for breast cancer with and without distant metastases. However, ... transplantation can more frequently give rise to severe complications ... of the final report of the Institute for Quality ...
Cached Medicine News:Health News:Gene Variant Could Lower Alzheimer's Risk 2Health News:Gene Variant Could Lower Alzheimer's Risk 3Health News:U.S. Preventive Medicine Appoints Ron Loeppke, MD, MPH, as Vice Chairman of the Board 2Health News:U.S. Preventive Medicine Appoints Ron Loeppke, MD, MPH, as Vice Chairman of the Board 3Health News:U.S. Preventive Medicine Appoints Ron Loeppke, MD, MPH, as Vice Chairman of the Board 4Health News:Could a Bigger Bottom Boost Health? 2Health News:Could a Bigger Bottom Boost Health? 3Health News:Hard To Treat Diseases (HTDS) To Disperse Special One Time Hiru (HIRU) Common Stock 2Health News:Hard To Treat Diseases (HTDS) To Disperse Special One Time Hiru (HIRU) Common Stock 3Health News:Hard To Treat Diseases (HTDS) To Disperse Special One Time Hiru (HIRU) Common Stock 4Health News:New ethical guidance from ACP for patient-physician-caregiver relationship 2Health News:Women with breast cancer may benefit from autologous stem cell transplantation 2Health News:Women with breast cancer may benefit from autologous stem cell transplantation 3Health News:Women with breast cancer may benefit from autologous stem cell transplantation 4
(Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced today ... been enrolled into the Company,s Phase 2 clinical trial. ... of Gem,s lead compound, GPX-150 (an investigational medication), in ... metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
(Date:1/22/2015)... Jan. 22, 2015  ResMed Inc. (NYSE: RMD ) ... Revenue for the quarter was $423.0 million, a 10 percent ... 14 percent increase on a constant currency basis). Net income ... the quarter ended December 31, 2013. Diluted earnings per share ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... catheter design was created to be ... still providing high suctioning efficiency. Our ... or 10 Fr) feature depth markings ... Our complete catheter line is available ...
Suction catheter with thumb valve, two eyes, whistle tip...
Tracheal Suction Latex Rubber Catheters - Thumb Control Valve...
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip....
Medicine Products: